FDA Extends Comment Period For Glucose Monitor Guidelines
This article was originally published in The Gray Sheet
Executive Summary
The agency is giving product developers and others an additional month to comment on draft guidelines, issued in January, that distinguish pre-market requirements for glucose meters employed in professional health care settings from those intended for self-monitoring by patients.